As previously reported, the issue of establishing personal jurisdiction when there is no causal link between defendant’s forum contacts and plaintiff’s claims was recently decided by the United States Supreme Court in Bristol-Myers Squibb Co. v. Superior Court of California, 137 S. Ct. 1773 (2017). Last week, the Bristol-Myers decision was applied by Judge Kleifield, presiding judge of Department 324 at the Los Angeles Superior Court, which oversees state court asbestos litigation for Counties of Los Angeles, San Diego, and Orange.
In Bristol-Myers, the Supreme Court considered whether a state court could exercise personal jurisdiction over the claims of non-resident plaintiffs against a non-resident corporate defendant for tortious injuries that occurred out of state. Bristol-Myers, 137 S. Ct. at 1778. Bristol-Myers Squib Company (“BMS”), incorporated in Delaware and headquartered in New York, had been sued in California state court by a group of plaintiffs, most of whom were not California residents, who alleged that a BMS drug damaged their health outside of California. Id. The non-resident plaintiffs had not alleged that they: (1) obtained the drug from any California source; (2) ingested the drug in California; or (3) were injured by the drug in California Id. However, it was established that BMS had some connections with California, as it sold the drug in the state. Id. at 1778. The Supreme Court reversed the decision of the California Supreme Court, which had held that there was specific jurisdiction over BMS. Id. at 1777, 1781.
The Supreme Court ruled that specific jurisdiction necessitates “an affiliation between the forum and underlying controversy, principally, [an] activity or an occurrence that takes place in the forum State.” Bristol-Myers, 137 S. Ct. at 1781 (quoting Goodyear Dunlop Tires Operations, S.A. v. Brown, 564 U.S. 915, 919 (2011)). It further held that in order for a state court to exercise specific jurisdiction, “the suit’ must ‘aris[e] out of or relat[e] to the defendant’s contacts with the forum.” Bristol-Myers, 137 S. Ct. at 1781 (quoting Daimler AGv. Bauman, 134 S. Ct. 746, 754 (2014)).
Applying those requirements, the Supreme Court found that California courts could not exercise specific jurisdiction over BMS with respect to non-residents’ claims because the non-residents did not claim to have suffered harm in California and all of the conduct giving rise to the non-residents’ claims occurred outside of California. Id. at 1782. Ultimately, the Supreme Court ruled that there was no specific jurisdiction because there was no connection between the forum and specific claims at issue. Id. at 1782.
In Herford, at al. v. AT&T Corp., et al., No. BC646315 (L.A. Super. Ct.), Tina Herford allegedly suffered exposure to asbestos-contaminated talc in California. The talc was allegedly supplied by defendant Whittaker, Clark & Daniels, Inc. (“WCD”). WCD and its successors, Brenntag North America, Inc. (“BNA”) and Brenntag Specialties, Inc. (“BSI”) moved to quash service of the summons for lack of personal jurisdiction.
Plaintiffs conceded that there was
Continue Reading Application of Bristol-Myers in the Los Angeles Superior Court